Theratechnologies, Inc.
(Toronto Stock Exchange : THTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. 1.82%78.560.7%$1560.18m
JNJJohnson & Johnson 2.49%164.100.7%$1002.11m
PFEPfizer Inc. 1.40%41.900.9%$929.64m
ABBVAbbVie, Inc. 0.47%107.931.9%$685.10m
BMYBristol-Myers Squibb Co. 0.82%57.411.0%$656.74m
LLYEli Lilly & Co. 0.64%240.521.1%$613.28m
AZNAstraZeneca Plc 1.38%60.111.0%$371.37m
NVSNovartis AG 1.13%83.270.2%$176.32m
GSKGlaxoSmithKline Plc 1.27%39.140.2%$162.00m
RGENRepligen Corp. 1.15%266.806.8%$119.31m
NVONovo Nordisk A/S 1.17%104.640.1%$91.69m
VTRSViatris, Inc. 0.37%13.540.0%$90.90m
EDSAEdesa Biotech, Inc. 5.75%8.190.0%$74.98m
SNYSanofi -0.46%47.810.2%$62.59m
CRVSCorvus Pharmaceuticals, Inc. -0.22%4.610.7%$56.38m

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montréal, Canada.